ERBB2 and neoplasm: With regard to tumor subtype at primary diagnosis, the time to recurrence was 55.27 months for luminal-A-like tumors, 45.84 months for luminal-B-like tumors, 35.19 months for HER2-enriched tumors, and 29.61 months for TNBC.